151 related articles for article (PubMed ID: 24565114)
1. Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression.
Gong H; Wu TT; Clarke EM
BMC Syst Biol; 2014; 8 Suppl 1(Suppl 1):S3. PubMed ID: 24565114
[TBL] [Abstract][Full Text] [Related]
2. A transcriptome analysis by lasso penalized Cox regression for pancreatic cancer survival.
Wu TT; Gong H; Clarke EM
J Bioinform Comput Biol; 2011 Dec; 9 Suppl 1():63-73. PubMed ID: 22144254
[TBL] [Abstract][Full Text] [Related]
3. Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data.
Wei P; Tang H; Li D
PLoS One; 2012; 7(10):e46887. PubMed ID: 23056513
[TBL] [Abstract][Full Text] [Related]
4. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
[TBL] [Abstract][Full Text] [Related]
5. Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer.
Wu C; Wu Z; Tian B
BMC Surg; 2020 Sep; 20(1):207. PubMed ID: 32943033
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
Li J; Tan W; Peng L; Zhang J; Huang X; Cui Q; Zheng J; Tan W; Wu C; Lin D
Cancer Commun (Lond); 2018 Apr; 38(1):13. PubMed ID: 29764514
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomic and functional profiling of the pancreatic cancer genome.
Shain AH; Salari K; Giacomini CP; Pollack JR
BMC Genomics; 2013 Sep; 14():624. PubMed ID: 24041470
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics method to analyze the mechanism of pancreatic cancer disorder.
Wang CJ; Xu RH; Yuan QY; Wang YK; Shen DW; Wang XJ; Gao W; Zhang H; Jiang H
J Comput Biol; 2013 Jun; 20(6):444-52. PubMed ID: 23614574
[TBL] [Abstract][Full Text] [Related]
10. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.
Xu Q; Fu R; Yin G; Liu X; Liu Y; Xiang M
Gene; 2016 Mar; 578(2):263-73. PubMed ID: 26719042
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
12. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
Dou D; Yang S; Lin Y; Zhang J
Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
[TBL] [Abstract][Full Text] [Related]
13. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
[TBL] [Abstract][Full Text] [Related]
14. Senescence-associated genes and non-coding RNAs function in pancreatic cancer progression.
Cheng Q; Ouyang X; Zhang R; Zhu L; Song X
RNA Biol; 2020 Nov; 17(11):1693-1706. PubMed ID: 31997706
[TBL] [Abstract][Full Text] [Related]
15. Expression of connective tissue growth factor in pancreatic cancer cell lines.
Kwon S; Munroe X; Crawley SC; Lee HY; Spong S; Bradham D; Gum JR; Sleisenger MH; Kim YS
Int J Oncol; 2007 Oct; 31(4):693-703. PubMed ID: 17786299
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.
Yachida S; White CM; Naito Y; Zhong Y; Brosnan JA; Macgregor-Das AM; Morgan RA; Saunders T; Laheru DA; Herman JM; Hruban RH; Klein AP; Jones S; Velculescu V; Wolfgang CL; Iacobuzio-Donahue CA
Clin Cancer Res; 2012 Nov; 18(22):6339-47. PubMed ID: 22991414
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes and candidate agents associated with pancreatic cancer.
Wang BS; Liu Z; Sun SL; Zhao Y
Tumour Biol; 2014 Jan; 35(1):81-8. PubMed ID: 23934415
[TBL] [Abstract][Full Text] [Related]
18. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
19. Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis.
Rückert F; Dawelbait G; Winter C; Hartmann A; Denz A; Ammerpohl O; Schroeder M; Schackert HK; Sipos B; Klöppel G; Kalthoff H; Saeger HD; Pilarsky C; Grützmann R
PLoS One; 2010 Aug; 5(8):e12243. PubMed ID: 20808857
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
